Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
NHS Blood and Transplant · Harvard University · +5 more institutions
Abstract
Bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Citation impact
- FWCI
- 85.33
- Percentile
- 100%
- References
- 26
Authors
10- ZDZachariah DeFilippCorresponding
NHS Blood and Transplant, Harvard University, Massachusetts General Hospital, Hesco (United States)
- PPPatricia P. Bloom
Harvard University, Massachusetts General Hospital, Center for Digestive and Liver Diseases, Hesco (United States)
- MTMariam Torres Soto
Harvard University, Massachusetts General Hospital, Office of Infectious Diseases, Hesco (United States)
- MKMichael K. Mansour
Harvard University, Massachusetts General Hospital, Office of Infectious Diseases, Hesco (United States)
- MSMohamad Sater
Zero Emissions Resource Organisation, Hesco (United States)
Topics & keywords
- Medicine
- Bacteremia
- Fecal bacteriotherapy
- Adverse effect
- Drug resistance
- Feces
- Clostridium difficile
- Clostridioides
- Good health and well-being